Adalimumab

PheWeb

RX_L04AB04

No definition available.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions None

321302

Filter registries

Medicine purchases: ATC L04AB04

1900

Check pre-conditions, main-only, mode, ICD version None

1690

Check minimum number of events

Min. number of events 3

1690

Include endpoints None

1690

RX_L04AB04

Extra metadata

First used in FinnGen datafreeze DF4

Similar endpoints

↥

List of similar endpoints to Adalimumab based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	1635	965	670
Unadjusted prevalence (%)	0.53	0.56	0.50
Mean age at first event (years)	46.71	46.33	47.25

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	0.05	4.37 [1.73, 11.06]	1.8e-3	21
15 years	-	-	-	-
5 years	-	-	-	-
1 year	-	-	-	-

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: RX_L04AB04 – Adalimumab
GWS hits:

Survival analyses between endpoints

↥

Plot

before Adalimumab
after Adalimumab

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Adalimumab

↥